A detailed history of Lcm Capital Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Lcm Capital Management Inc holds 3,255 shares of NVS stock, worth $320,292. This represents 0.22% of its overall portfolio holdings.

Number of Shares
3,255
Previous 3,202 1.66%
Holding current value
$320,292
Previous $340,000 10.0%
% of portfolio
0.22%
Previous 0.21%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$106.13 - $120.89 $5,624 - $6,407
53 Added 1.66%
3,255 $374,000
Q2 2024

Aug 01, 2024

BUY
$92.57 - $107.37 $7,961 - $9,233
86 Added 2.76%
3,202 $340,000
Q1 2024

May 06, 2024

BUY
$95.27 - $108.47 $1,524 - $1,735
16 Added 0.52%
3,116 $301,000
Q4 2023

Feb 05, 2024

BUY
$92.27 - $101.54 $1,660 - $1,827
18 Added 0.58%
3,100 $313,000
Q3 2023

Nov 07, 2023

BUY
$94.73 - $105.13 $12,125 - $13,456
128 Added 4.33%
3,082 $313,000
Q2 2023

Aug 11, 2023

BUY
$92.52 - $104.91 $6,291 - $7,133
68 Added 2.36%
2,954 $298,000
Q1 2023

May 01, 2023

BUY
$80.03 - $92.81 $13,845 - $16,056
173 Added 6.38%
2,886 $265,000
Q4 2022

Jan 24, 2023

BUY
$75.55 - $92.52 $831 - $1,017
11 Added 0.41%
2,713 $0
Q3 2022

Oct 14, 2022

SELL
$74.61 - $87.26 $746 - $872
-10 Reduced 0.37%
2,702 $205,000
Q2 2022

Jul 28, 2022

SELL
$80.52 - $93.75 $1,610 - $1,875
-20 Reduced 0.73%
2,712 $229,000
Q1 2022

Apr 18, 2022

BUY
$80.11 - $90.62 $3,925 - $4,440
49 Added 1.83%
2,732 $240,000
Q4 2021

Jan 24, 2022

BUY
$79.7 - $88.13 $9,404 - $10,399
118 Added 4.6%
2,683 $235,000
Q3 2021

Oct 15, 2021

BUY
$81.78 - $95.14 $408 - $475
5 Added 0.2%
2,565 $210,000
Q2 2021

Jul 21, 2021

BUY
$85.24 - $94.15 $2,898 - $3,201
34 Added 1.35%
2,560 $234,000
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $8,016 - $9,453
-96 Reduced 3.66%
2,526 $216,000
Q4 2020

May 12, 2021

BUY
$78.07 - $94.43 $204,699 - $247,595
2,622 New
2,622 $245,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Lcm Capital Management Inc Portfolio

Follow Lcm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lcm Capital Management Inc with notifications on news.